SCHEMBL4428496

SCHEMBL4428496

CNCCc1cnc(F)cc1-c1cccc2cc(-c3nc(NCCN4CCNC4=O)ncc3F)sc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 4/20 0.36
IRAK1 P51617 1/20 0.36
IRAK4 Q9NWZ3 1/20 0.36
BRAF P15056 5/20 0.33
RAF1 P04049 4/20 0.33
CACNA2D1 P54289 1/20 0.32
CCND1 P24385 6/20 0.31
CDK6 Q00534 4/20 0.31
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
CDK4 P11802 3/20 0.30
PDCD1 Q15116 1/20 0.30
CD274 Q9NZQ7 1/20 0.30
CCNT1 O60563 1/20 0.30
CCNA2 P20248 1/20 0.30
CDK2 P24941 1/20 0.30
CCND3 P30281 1/20 0.30
CDK7 P50613 1/20 0.30
CDK9 P50750 1/20 0.30
CCNH P51946 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1339001 0.95 SCN9A (0.37) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL2876430 0.93 SCN9A (0.35) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL4435734 0.93 SCN9A (0.37) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL394212 0.91 SCN9A (0.38) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL1337981 0.91 SCN9A (0.37) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL392585 0.91 SCN9A (0.39) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL1339273 0.90 SCN9A (0.36) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL1337516 0.90 SCN9A (0.36) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL1339089 0.89 SCN9A (0.35) SCN9AIRAK1IRAK4BRAFRAF1
SCHEMBL1340224 0.89 SCN9A (0.36) SCN9AIRAK1IRAK4BRAFRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125794-A1 IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER Eli Lilly & Company (US) 2009-12-02 EP disclosed
WO-2008076705-A1 IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER ELI LILLY AND COMPANY (US) 2008-06-26 WO disclosed